Redox control of inflammation in macrophages

Antioxidants and Redox Signaling

Volumn 19, Issue 6, 2013, Pages 595-637

  Brüne, Bernhard ^a   Dehne, Nathalie ^a   Grossmann, Nina ^a   Jung, Michaela ^a   Namgaladze, Dmitry ^a   Schmid, Tobias ^a   Von Knethen, Andreas ^a   Weigert, Andreas ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYLAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; NITRITE; NITROGEN DIOXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TRANSCRIPTION FACTOR NRF2;

BIOLOGICAL ACTIVITY; CELL DEATH; CELL FUNCTION; CELL INTERACTION; CYTOLOGY; ENDOPLASMIC RETICULUM STRESS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATION REDUCTION REACTION; PHAGOCYTE; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL HYPOXIA; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84880672271     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4785     Document Type: Review

References (345)

1. Adamson S and Leitinger N. Phenotypic modulation of macrophages in response to plaque lipids. Curr Opin Lipidol 22: 335-342, 2011.
2. Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, Guan KL, Shen J, Person MD, Kusewitt D, Mills GB, Kastan MB, and Walker CL. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107: 4153-4158, 2010.
3. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 113: 1251-1253, 2004.
4. Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, Andre F, Tursz T, Kroemer G, and Zitvogel L. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 220: 47-59, 2007.
5. Ariel A and Serhan CN. New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front Immunol 3: 4, 2012.
6. Babaev VR, Yancey PG, Ryzhov SV, Kon V, Breyer MD, Magnuson MA, Fazio S, and Linton MF. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 25: 1647-1653, 2005.
7. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, Munn DH, and Mellor AL. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183: 2475-2483, 2009.
8. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL, and Miller YI Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4-and spleen tyrosine kinasedependent activation of NADPH oxidase Circ Res 104, 210-218, 2009
9. Barra V, Kuhn AM, von Knethen A, Weigert A, and Brune B. Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/ CREB. Cell Mol Life Sci 68: 1815-1827, 2011.
10. Bauer M, Goldstein M, Christmann M, Becker H, Heylmann D, and Kaina B. Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc Natl Acad Sci U S A 108: 21105-21110, 2011.
11. Bauernfeind F, Bartok E, Rieger A, Franchi L, Nunez G, and Hornung V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 187: 613-617, 2011.
12. Bertrand JY, Jalil A, Klaine M, Jung S, Cumano A, and Godin I. Three pathways to mature macrophages in the early mouse yolk sac. Blood 106: 3004-3011, 2005.
13. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5, 2007.
14. Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, McGovern N, Jardine L, Pagan S, Dimmick I, Chua I, Wallis J, Lordan J, Morgan C, Kumararatne DS, Doffinger R, van der Burg M, van Dongen J, Cant A, Dick JE, Hambleton S, and Collin M. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208: 227-234, 2011.
15. Blanc J, Alves-Guerra MC, Esposito B, Rousset S, Gourdy P, Ricquier D, Tedgui A, Miroux B, and Mallat Z. Protective role of uncoupling protein 2 in atherosclerosis. Circulation 107: 388-390, 2003.
16. Blanquicett C, Kang BY, Ritzenthaler JD, Jones DP, and Hart CM. Oxidative stress modulates PPAR gamma in vascular endothelial cells. Free Radic Biol Med 48: 1618-1625, 2010.
17. Bogdan C. Nitric oxide and the regulation of gene expression. Trends Cell Biol 11: 66-75, 2001.
18. Bolignano D, Coppolino G, Donato V, Lacquaniti A, Bono C, and Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle?. Med Sci Monit 16: RA131-RA135, 2010.
19. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, and Gorlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27: 755-761, 2007.
20. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, and Chinetti-Gbaguidi G. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 6: 137-143, 2007.
21. Broichhausen C, Riquelme P, Geissler EK, and Hutchinson JA. Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation. Curr Opin Organ Transplant 17: 332-342, 2012.
22. Brown KL, Christenson K, Karlsson A, Dahlgren C, and Bylund J. Divergent effects on phagocytosis by macrophage-derived oxygen radicals. J Innate Immun 1: 592-598, 2009.
23. Brune B. The intimate relation between nitric oxide and superoxide in apoptosis and cell survival. Antioxid Redox Signal 7: 497-507, 2005.
24. Brune B and Dehne N. Sensors, transmitters and targets in mitochondrial oxygen shortage-A HIF relay story Antioxid Redox Signal 2012 [Epub ahead of print]; DOI: ARS-2012-4776.
25. Brune B and Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc Res 75: 275-282, 2007.
26. Bylund J, Brown KL, Movitz C, Dahlgren C, and Karlsson A. Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for?. Free Radic Biol Med 49: 1834-1845, 2010.
27. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, and Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458: 1056-1060, 2009.
28. Carta S, Tassi S, Pettinati I, Delfino L, Dinarello CA, and Rubartelli A. The rate of interleukin-1beta secretion in different myeloid cells varies with the extent of redox response to toll-like receptor triggering. J Biol Chem 286: 27069-27080, 2011.
29. Chamberlain CS, Leiferman EM, Frisch KE, Wang S, Yang X, Brickson SL, and Vanderby R. The influence of interleukin-4 on ligament healing. Wound Repair Regen 19: 426-435, 2011.
30. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, and Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 95: 11715-11720, 1998.
31. Chang MK, Bergmark C, Laurila A, Horkko S, Han KH, Friedman P, Dennis EA, and Witztum JL. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A 96: 6353-6358, 1999.
32. Chang MK, Binder CJ, Torzewski M, and Witztum JL. Creactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A 99: 13043-13048, 2002.
33. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, and Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7: 161-171, 2001.
34. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, and Kleeberger SR. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 26: 175-182, 2002.
35. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, Backhed F, Miller YI, Horkko S, Corr M, Witztum JL, and Binder CJ. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119: 1335-1349, 2009.
36. Chowdhury R, Flashman E, Mecinovic J, Kramer HB, Kessler BM, Frapart YM, Boucher JL, Clifton IJ, McDonough MA, and Schofield CJ. Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1). J Mol Biol 410: 268-279, 2011.
37. Chua YL, Dufour E, Dassa EP, Rustin P, Jacobs HT, Taylor CT, and Hagen T. Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J Biol Chem 285: 31277-31284, 2010.
38. Clements CM, McNally RS, Conti BJ, Mak TW, and Ting JP. DJ-1, a cancer-and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A 103: 15091-15096, 2006.
39. Cockman ME, Lancaster DE, Stolze IP, Hewitson KS, McDonough MA, Coleman ML, Coles CH, Yu X, Hay RT, Ley SC, Pugh CW, Oldham NJ, Masson N, Schofield CJ, and Ratcliffe PJ. Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc Natl Acad Sci U S A 103: 14767-14772, 2006.
40. Cole C, Thomas S, Filak H, Henson PM, and Lenz LL. Nitric oxide increases susceptibility of toll-like receptoractivated macrophages to spreading listeria monocytogenes. Immunity 36: 807-820, 2012.
41. Collins AR, Meehan WP, Kintscher U, Jackson S, Wakino S, Noh G, Palinski W, Hsueh WA, and Law RE. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 21: 365-371, 2001.
42. Colombo SL and Moncada S. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 421: 163-169, 2009.
43. Corna G, Campana L, Pignatti E, Castiglioni A, Tagliafico E, Bosurgi L, Campanella A, Brunelli S, Manfredi AA, Apostoli P, Silvestri L, Camaschella C, and Rovere-Querini P. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 95: 1814-1822, 2010.
44. Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T, McCaffrey TV, McCaffrey JC, and Gabrilovich DI. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 207: 2439-2453, 2010.
45. Cowland JB, Sorensen OE, Sehested M, and Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNFalpha. J Immunol 171: 6630-6639, 2003.
46. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, and Johnson RS. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112: 645-657, 2003.
47. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, and Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282: 2871-2879, 2007.
48. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouyssegur J, and Taylor CT. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 103: 18154-18159, 2006.
49. Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, and Taylor CT. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134: 156-165, 2008.
50. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, and Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742, 1993.
51. Daynes RA and Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2: 748-759, 2002.
52. Degrossoli A, Arrais-Silva WW, Colhone MC, Gadelha FR, Joazeiro PP, and Giorgio S. The influence of low oxygen on macrophage response to Leishmania infection. Scand J Immunol 74: 165-175, 2011.
53. Dehne N and Brune B. HIF-1 in the inflammatory microenvironment. Exp Cell Res 315: 1791-1797, 2009.
54. Deretic V. Autophagy: an emerging immunological paradigm. J Immunol 189: 15-20, 2012.
55. Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, Derijard B, Desvergne B, Wahli W, Chambon P, Leibowitz MD, Colombel JF, and Auwerx J. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferatoractivated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med 193: 827-838, 2001.
56. Desvergne B, Michalik L, and Wahli W. Transcriptional regulation of metabolism. Physiol Rev 86: 465-514, 2006.
57. Devireddy LR, Gazin C, Zhu X, and Green MR. A cellsurface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123: 1293-1305, 2005.
58. Doedens AL, Stockmann C, Rubinstein MP, Liao D, Zhang N, DeNardo DG, Coussens LM, Karin M, Goldrath AW, and Johnson RS. Macrophage expression of hypoxiainducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 70: 7465-7475, 2010.
59. Doege K, Heine S, Jensen I, Jelkmann W, and Metzen E. Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 106: 2311-2317, 2005.
60. Dudzinski DM and Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res 75: 247-260, 2007.
61. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, and Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361, 2010.
62. Echtay KS, Esteves TC, Pakay JL, Jekabsons MB, Lambert AJ, Portero-Otin M, Pamplona R, Vidal-Puig AJ, Wang S, Roebuck SJ, and Brand MD. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 22: 4103-4110, 2003.
63. Edwards JP, Zhang X, Frauwirth KA, and Mosser DM. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 80: 1298-1307, 2006.
64. El-Benna J, Dang PM, Gougerot-Pocidalo MA, and Elbim C. Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp (Warsz) 53: 199-206, 2005.
65. Essler S, Dehne N, and Brune B. Role of sestrin2 in peroxide signaling in macrophages. FEBS Lett 583: 3531-3535, 2009.
66. Eubank TD, Roda JM, Liu H, O'Neil T, and Marsh CB. Opposing roles for HIF-1alpha and HIF-2alpha in the regulation of angiogenesis by mononuclear phagocytes. Blood 117: 323-332, 2011.
67. Fang HY, Hughes R, Murdoch C, Coffelt SB, Biswas SK, Harris AL, Johnson RS, Imityaz HZ, Simon MC, Fredlund E, Greten FR, Rius J, and Lewis CE. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114: 844-859, 2009.
68. Feng Y, Santoriello C, Mione M, Hurlstone A, and Martin P. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol 8: e1000562, 2010.
69. Filardy AA, Pires DR, Nunes MP, Takiya CM, Freire-de-Lima CG, Ribeiro-Gomes FL, and DosReis GA. Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages. J Immunol 185: 2044-2050, 2010.
70. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, Pandolfi PP, and Haigis MC. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 19: 416-428, 2011.
71. Fitzpatrick SF, Tambuwala MM, Bruning U, Schaible B, Scholz CC, Byrne A, O'Connor A, Gallagher WM, Lenihan CR, Garvey JF, Howell K, Fallon PG, Cummins EP, and Taylor CT. An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia. J Immunol 186: 1091-1096, 2011.
72. Fleming BD and Mosser DM. Regulatory macrophages: setting the threshold for therapy. Eur J Immunol 41: 2498-2502, 2011.
73. Flohe L, Toppo S, Cozza G, and Ursini F. A comparison of thiol peroxidase mechanisms. Antioxid Redox Signal 15: 763-780, 2011.
74. Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, Littman DR, Cumano A, and Geissmann F. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311: 83-87, 2006.
75. Forman HJ and Torres M. Redox signaling in macrophages. Mol Aspects Med 22: 189-216, 2001.
76. Foster SL, Hargreaves DC, and Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978, 2007.
77. Freigang S, Ampenberger F, Spohn G, Heer S, Shamshiev AT, Kisielow J, Hersberger M, Yamamoto M, Bachmann MF, and Kopf M. Nrf2 is essential for cholesterol crystalinduced inflammasome activation and exacerbation of atherosclerosis. Eur J Immunol 41: 2040-2051, 2011.
78. Frein D, Schildknecht S, Bachschmid M, and Ullrich V. Redox regulation: a new challenge for pharmacology. Biochem Pharmacol 70: 811-823, 2005.
79. Fruehauf JP and Meyskens FL, Jr. Reactive oxygen species: a breath of life or death?. Clin Cancer Res 13: 789-794, 2007.
80. Gabrilovich DI, Ostrand-Rosenberg S, and Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12: 253-268, 2012.
81. Gaetano C, Massimo L, and Alberto M. Control of iron homeostasis as a key component of macrophage polarization. Haematologica 95: 1801-1803, 2010.
82. Galic S, Fullerton MD, Schertzer JD, Sikkema S, Marcinko K, Walkley CR, Izon D, Honeyman J, Chen ZP, van Denderen BJ, Kemp BE, and Steinberg GR. Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 121: 4903-4915, 2011.
83. Galli SJ, Borregaard N, and Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12: 1035-1044, 2011.
84. Garedew A, Henderson SO, and Moncada S. Activated macrophages utilize glycolytic ATP to maintain mitochondrial membrane potential and prevent apoptotic cell death. Cell Death Differ 17: 1540-1550, 2010.
85. Geissmann F, Jung S, and Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82, 2003.
86. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, and Ley K. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661, 2010.
87. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouyssegur J, Yaniv M, and Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118: 781-794, 2004.
88. Ghafourifar P and Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 26: 190-195, 2005.
89. Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, Bortoluci KR, Almeida SR, Herzenberg LA, and Herzenberg LA. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A 107: 2568-2573, 2010.
90. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, and MeradM. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845, 2011.
91. Gladwin MT, Grubina R, and Doyle MP. The new chemical biology of nitrite reactions with hemoglobin: R-state catalysis, oxidative denitrosylation, and nitrite reductase/anhydrase. Acc Chem Res 42: 157-167, 2009.
92. Gloire G, Legrand-Poels S, and Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72: 1493-1505, 2006.
93. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 3: 23-35, 2003.
94. Gordon S and Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964, 2005.
95. Goven D, Boutten A, Lecon-Malas V, Marchal-Somme J, Soler P, Boczkowski J, and Bonay M. Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneumothorax: role of HIF-1alpha. PLoS One 5: e10886, 2010.
96. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, and Gallick GE. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 24: 3110-3120, 2005.
97. Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, and Hazen SL. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 203: 2613-2625, 2006.
98. Greer SN, Metcalf JL, Wang Y, and Ohh M. The updated biology of hypoxia-inducible factor. Embo J 31: 2448-2460, 2012.
99. Gregory CD and Pound JD. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J Pathol 223: 177-194, 2010.
100. Guo RF and Ward PA. Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 9: 1991-2002, 2007.
101. Gutierrez J, Ballinger SW, Darley-Usmar VM, and Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 99: 924-932, 2006.
102. Hagen T, Taylor CT, Lam F, and Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302: 1975-1978, 2003.
103. Handa P, Tateya S, Rizzo NO, Cheng AM, Morgan-Stevenson V, Han CY, Clowes AW, Daum G, O'Brien KD, Schwartz MW, Chait A, and Kim F. Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding. Arterioscler Thromb Vasc Biol 31: 2827-2835, 2011.
104. Hanna RN, Shaked I, Hubbeling HG, Punt JA, Wu R, Herrley E, Zaugg C, Pei H, Geissmann F, Ley K, and Hedrick CC. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res 110: 416-427, 2012.
105. Hardie DG, Ross FA, and Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13: 251-262, 2012.
106. Harkewicz R, Hartvigsen K, Almazan F, Dennis EA, Witztum JL, and Miller YI. Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein. J Biol Chem 283: 10241-10251, 2008.
107. Harris J, Hartman M, Roche C, Zeng SG, O'Shea A, Sharp FA, Lambe EM, Creagh EM, Golenbock DT, Tschopp J, Kornfeld H, Fitzgerald KA, and Lavelle EC. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 286: 9587-9597, 2011.
108. Harvey CJ, Thimmulappa RK, Sethi S, Kong X, Yarmus L, Brown RH, Feller-Kopman D, Wise R, and Biswal S. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med 3: 78ra32, 2011.
109. Hashimoto D, Miller J, and Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35: 323-335, 2011.
110. Hazen SL. Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. J Biol Chem 283: 15527-15531, 2008.
111. He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AM, and Alam J. Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem 276: 20858-20865, 2001.
112. Heinloth A, Brune B, Fischer B, and Galle J. Nitric oxide prevents oxidised LDL-induced p53 accumulation, cytochrome c translocation, and apoptosis in macrophages via guanylate cyclase stimulation. Atherosclerosis 162: 93-101, 2002.
113. Herr B, Zhou J, Werno C, Menrad H, Namgaladze D, Weigert A, Dehne N, and Brune B. The supernatant of apoptotic cells causes transcriptional activation of hypoxiainducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta. Blood 114: 2140-2148, 2009.
114. Hess DT and Stamler JS. Regulation by S-nitrosylation of protein post-translational modification. J Biol Chem 287: 4411-4418, 2012.
115. Hibbs JB, Jr., Taintor RR, and Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473-476, 1987.
116. Hill BG, Dranka BP, Bailey SM, Lancaster JR, Jr., and Darley-Usmar VM. What part of NO don't you understand?. Some answers to the cardinal questions in nitric oxide biology. J Biol Chem 285: 19699-19704, 2010.
117. Hindryckx P, De Vos M, Jacques P, Ferdinande L, Peeters H, Olievier K, Bogaert S, Brinkman B, Vandenabeele P, Elewaut D, and Laukens D. Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD. J Immunol 185: 6306-6316, 2010.
118. Hoetzenecker W, Echtenacher B, Guenova E, Hoetzenecker K, Woelbing F, Bruck J, Teske A, Valtcheva N, Fuchs K, Kneilling M, Park JH, Kim KH, Kim KW, Hoffmann P, Krenn C, Hai T, Ghoreschi K, Biedermann T, and Rocken M. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med 18: 128-134, 2012.
119. Hollander AP, Corke KP, Freemont AJ, and Lewis CE. Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 44: 1540-1544, 2001.
120. Hu Q, Zhang XJ, Liu CX, Wang XP, and Zhang Y. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice. J Vasc Res 47: 69-79, 2010.
121. Huang C, Han Y, Wang Y, Sun X, Yan S, Yeh ET, Chen Y, Cang H, Li H, Shi G, Cheng J, Tang X, and Yi J. SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. Embo J 28: 2748-2762, 2009.
122. Huang Z, Hoffmann FW, Fay JD, Hashimoto AC, Chapagain ML, Kaufusi PH, and Hoffmann PR. Stimulation of unprimed macrophages with immune complexes triggers a low output of nitric oxide by calciumdependent neuronal nitric-oxide synthase. J Biol Chem 287: 4492-4502, 2011.
123. Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol 181: 5829-5835, 2008.
124. Igwe EI, Essler S, Al-Furoukh N, Dehne N, and Brune B. Hypoxic transcription gene profiles under the modulation of nitric oxide in nuclear run on-microarray and proteomics. BMC Genomics 10: 408, 2009.
125. Imtiyaz HZ, Williams EP, Hickey MM, Patel SA, Durham AC, Yuan LJ, Hammond R, Gimotty PA, Keith B, and Simon MC. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 120: 2699-2714, 2010.
126. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, and Mann GE. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94: 609-616, 2004.
127. Itoh K, Igarashi K, Hayashi N, Nishizawa M, and Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 15: 4184-4193, 1995.
128. Janssen WJ and Henson PM. Cellular regulation of the inflammatory response. Toxicol Pathol 40: 166-173, 2012.
129. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, van Rooijen N, MacDonald AS, and Allen JE. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332: 1284-1288, 2011.
130. Jennewein C, Kuhn AM, Schmidt MV, Meilladec-Jullig V, von Knethen A, Gonzalez FJ, and Brune B. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J Immunol 181: 5646-5652, 2008.
131. Jiang C, Ting AT, and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86, 1998.
132. Johann AM, von Knethen A, Lindemann D, and Brune B. Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. Cell Death Differ 13: 1533-1540, 2006.
133. Jourd'heuil D, Mai CT, Laroux FS, Wink DA, and Grisham MB. The reaction of S-nitrosoglutathione with superoxide. Biochem Biophys Res Commun 246: 525-530, 1998.
134. Jourd'heuil D, Miranda KM, Kim SM, Espey MG, Vodovotz Y, Laroux S, Mai CT, Miles AM, Grisham MB, and Wink DA. The oxidative and nitrosative chemistry of the nitric oxide/superoxide reaction in the presence of bicarbonate. Arch Biochem Biophys 365: 92-100, 1999.
135. Judkins CP, Diep H, Broughton BR, Mast AE, Hooker EU, Miller AA, Selemidis S, Dusting GJ, Sobey CG, and Drummond GR. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/-mice. Am J Physiol Heart Circ Physiol 298: H24-H32, 2010.
136. Jung JE, Kim HS, Lee CS, Shin YJ, Kim YN, Kang GH, Kim TY, Juhnn YS, Kim SJ, Park JW, Ye SK, and Chung MH. STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination. Exp Mol Med 40: 479-485, 2008.
137. Jung M, Sola A, Hughes J, Kluth DC, Vinuesa E, Vinas JL, Perez-Ladaga A, and Hotter G. Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2. Kidney Int 81: 969-982, 2012.
138. Kaelin WG, Jr. and Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30: 393-402, 2008.
139. Kagan VE, Borisenko GG, Serinkan BF, Tyurina YY, Tyurin VA, Jiang J, Liu SX, Shvedova AA, Fabisiak JP, Uthaisang W, and Fadeel B. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine. Am J Physiol Lung Cell Mol Physiol 285: L1-L17, 2003.
140. Kanayama M, Yamaguchi S, Shibata T, Shibata N, Kobayashi M, Nagai R, Arai H, Takahashi K, and Uchida K. Identification of a serum component that regulates cyclooxygenase-2 gene expression in cooperation with 4-hydroxy-2-nonenal. J Biol Chem 282: 24166-24174, 2007.
141. Kaufmann SH. Immunology's foundation: the 100-year anniversary of the nobel prize to Paul Ehrlich and Elie Metchnikoff. Nat Immunol 9: 705-712, 2008.
142. Kawamoto H, Ikawa T, Masuda K, Wada H, and Katsura Y. A map for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid-based model. Immunol Rev 238: 23-36, 2010.
143. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, and Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29: 21-32, 2008.
144. Keith B, Johnson RS, and Simon MC. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12: 9-22, 2012.
145. Kelleher ZT, Potts EN, Brahmajothi MV, Foster MW, Auten RL, Foster WM, and Marshall HE. NOS2 regulation of LPS-induced airway inflammation via S-nitrosylation of NF-{kappa}B p65. Am J Physiol Lung Cell Mol Physiol 301: L327-L333, 2011.
146. Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, Reger RN, Leonardi AJ, Morgan RA, Wang E, Marincola FM, Trinchieri G, Rosenberg SA, and Restifo NP. IL-12 triggers a programmatic change in dysfunctional myeloidderived cells within mouse tumors. J Clin Invest 121: 4746-4757, 2011.
147. Kiemer AK, Hartung T, and Vollmar AM. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J Immunol 165: 175-181, 2000.
148. Kim H, Jung Y, Shin BS, Kim H, Song H, Bae SH, Rhee SG, and Jeong W. Redox regulation of lipopolysaccharide-mediated sulfiredoxin induction, which depends on both AP-1 and Nrf2. J Biol Chem 285: 34419-34428, 2010.
149. Kiss J, Mollenhauer M, Walmsley SR, Kirchberg J, Radhakrishnan P, Niemietz T, Dudda J, Steinert G, Whyte MK, Carmeliet P, Mazzone M, Weitz J, and Schneider M. Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis. J Immunol 189: 1955-1965, 2012.
150. Knowles HJ, Raval RR, Harris AL, and Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63: 1764-1768, 2003.
151. Kobayashi M, Tsuda Y, Yoshida T, Takeuchi D, Utsunomiya T, Takahashi H, and Suzuki F. Bacterial sepsis and chemokines. Curr Drug Targets 7: 119-134, 2006.
152. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol 88: 1157-1162, 2010.
153. Kong X, Thimmulappa R, Craciun F, Harvey C, Singh A, Kombairaju P, Reddy SP, Remick D, and Biswal S. Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. Am J Respir Crit Care Med 184: 928-938, 2011.
154. Kong X, Thimmulappa R, Kombairaju P, and Biswal S. NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice. J Immunol 185: 569-577, 2010.
155. Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P, and Giaccia AJ. Hypoxic activation of nuclear factorkappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res 54: 5273-5279, 1994.
156. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW, Holmdahl R, van Kooten C, and Gelderman KA. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A 107: 17686-17691, 2010.
157. Kraaij MD, van der Kooij SW, Reinders ME, Koekkoek K, Rabelink TJ, van Kooten C, and Gelderman KA. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Mol Immunol 49: 549-557, 2011.
158. Kraft-Terry SD and Gendelman HE. Proteomic biosignatures for monocyte-macrophage differentiation. Cell Immunol 271: 239-255, 2011.
159. Kuhn AM, Tzieply N, Schmidt MV, von Knethen A, Namgaladze D, Yamamoto M, and Brune B. Antioxidant signaling via Nrf2 counteracts lipopolysaccharide- mediated inflammatory responses in foam cell macrophages. Free Radic Biol Med 50: 1382-1391, 2011.
160. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Matsumura T, and Araki E. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55: 120-127, 2006.
161. Lambeth JD, Kawahara T, and Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 43: 319-331, 2007.
162. Lancaster JR, Jr. and Hibbs JB, Jr. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A 87: 1223-1227, 1990.
163. Lawrence T and Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11: 750-761, 2011.
164. Lee CF, Qiao M, Schroder K, Zhao Q, and Asmis R. Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death. Circ Res 106: 1489-1497, 2010.
165. Lee S, Gharavi NM, Honda H, Chang I, Kim B, Jen N, Li R, Zimman A, and Berliner JA. A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids. Free Radic Biol Med 47: 145-151, 2009.
166. Leto TL, Morand S, Hurt D, and Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 11: 2607-2619, 2009.
167. Ley S, Weigert A, and Brune B. Neuromediators in inflammation-A macrophage/nerve connection. Immunobiology 215: 674-684, 2010.
168. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, and Glass CK. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106: 523-531, 2000.
169. Li B, Bedard K, Sorce S, Hinz B, Dubois-Dauphin M, and Krause KH. NOX4 expression in human microglia leads to constitutive generation of reactive oxygen species and to constitutive IL-6 expression. J Innate Immun 1: 570-581, 2009.
170. Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, Vujaskovic Z, Dewhirst MW, and Li CY. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell 26: 63-74, 2007.
171. Li G, Mongillo M, Chin KT, Harding H, Ron D, Marks AR, and Tabas I. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol 186: 783-792, 2009.
172. Li G, Scull C, Ozcan L, and Tabas I. NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. J Cell Biol 191: 1113-1125, 2010.
173. Li W, Yu S, Liu T, Kim JH, Blank V, Li H, and Kong AN. Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif. Biochim Biophys Acta 1783: 1847-1856, 2008.
174. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J, and Tabas I. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 15: 545-553, 2012.
175. Lim SY, Raftery MJ, Goyette J, Hsu K, and Geczy CL. Oxidative modifications of S100 proteins: functional regulation by redox. J Leukoc Biol 86: 577-587, 2009.
176. Loker ES, Adema CM, Zhang SM, and Kepler TB. Invertebrate immune systems-not homogeneous, not simple, not well understood. Immunol Rev 198: 10-24, 2004.
177. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, Roers A, and Eming SA. Differential roles of macrophages in diverse phases of skin repair. J Immunol 184: 3964-3977, 2010.
178. Mackaness GB. The immunological basis of acquired cellular resistance. J Exp Med 120: 105-120, 1964.
179. Mahabeleshwar GH, Qureshi MA, Takami Y, Sharma N, Lingrel JB, and Jain MK. A myeloid hypoxia-inducible factor 1alpha-Kruppel-like factor 2 pathway regulates gram-positive endotoxin-mediated sepsis. J Biol Chem 287: 1448-1457, 2012.
180. Mailloux RJ and Harper ME. Uncoupling proteins and the control of mitochondrial reactive oxygen species production. Free Radic Biol Med 51: 1106-1115, 2011.
181. Malhotra D, Thimmulappa RK, Mercado N, Ito K, Kombairaju P, Kumar S, Ma J, Feller-Kopman D, Wise R, Barnes P, and Biswal S. Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. J Clin Invest 121: 4289-4302, 2011.
182. Mantovani A, Sozzani S, Locati M, Allavena P, and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002.
183. Marathe C, Bradley MN, Hong C, Chao L, Wilpitz D, Salazar J, and Tontonoz P. Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARgamma-/-, PPARdelta-/-, PPARgammadelta-/-, or LXRalphabeta-/-bone marrow. J Lipid Res 50: 214-224, 2009.
184. Masson N, Singleton RS, Sekirnik R, Trudgian DC, Ambrose LJ, Miranda MX, Tian YM, Kessler BM, Schofield CJ, and Ratcliffe PJ. The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity. EMBO Rep 13: 251-257, 2012.
185. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nunez G, Yodoi J, Kahn SE, Lavelle EC, and O'Neill LA. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nature Immunol 11: 897-904, 2010.
186. McGovern NN, Cowburn AS, Porter L, Walmsley SR, Summers C, Thompson AA, Anwar S, Willcocks LC, Whyte MK, Condliffe AM, and Chilvers ER. Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils. J Immunol 186: 453-463, 2011.
187. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, and Maki RA. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. Embo J 15: 5647-5658, 1996.
188. Meissner F, Molawi K, and Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nature Immunol 9: 866-872, 2008.
189. Melillo G, Taylor LS, Brooks A, Cox GW, and Varesio L. Regulation of inducible nitric oxide synthase expression in IFN-gamma-treated murine macrophages cultured under hypoxic conditions. J Immunol 157: 2638-2644, 1996.
190. Mendonca DB, Mendonca G, Aragao FJ, and Cooper LF. NF-kappaB suppresses HIF-1alpha response by competing for P300 binding. Biochem Biophys Res Commun 404: 997-1003, 2011.
191. Menu P, Mayor A, Zhou R, Tardivel A, Ichijo H, Mori K, and Tschopp J. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis 3: e261, 2012.
192. Metukuri MR, Namas R, Gladstone C, Clermont T, Jefferson B, Barclay D, Hermus L, Billiar TR, Zamora R, and Vodovotz Y. Activation of latent transforming growth factor-beta1 by nitric oxide in macrophages: role of soluble guanylate cyclase and MAP kinases. Wound Repair Regen 17: 578-588, 2009.
193. Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, Pandey G, Leboeuf M, Elpek KG, Helft J, Hashimoto D, Chow A, Price J, Greter M, Bogunovic M, Bellemare-Pelletier A, Frenette PS, Randolph GJ, Turley SJ, and Merad M. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol 13: 888-899, 2012.
194. Miller YI, Choi SH, Fang L, and Harkewicz R. Toll-like receptor-4 and lipoprotein accumulation in macrophages. Trends Cardiovasc Med 19: 227-232, 2009.
195. Mills CD, Kincaid K, Alt JM, Heilman MJ, and Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164: 6166-6173, 2000.
196. Moore SF and MacKenzie AB. NADPH oxidase NOX2 mediates rapid cellular oxidation following ATP stimulation of endotoxin-primed macrophages. J Immunol 183: 3302-3308, 2009.
197. Morgan MJ and Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21: 103-115, 2011.
198. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, and Barasch J. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115: 610-621, 2005.
199. Mosser DM and Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969, 2008.
200. Muller PA, van de Sluis B, Groot AJ, Verbeek D, Vonk WI, Maine GN, Burstein E, Wijmenga C, Vooijs M, Reits E, and Klomp LW. Nuclear-cytosolic transport of COMMD1 regulates NF-kappaB and HIF-1 activity. Traffic 10: 514-527, 2009.
201. Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 158: 638-651, 2009.
202. Mungai PT, Waypa GB, Jairaman A, Prakriya M, Dokic D, Ball MK, and Schumacker PT. Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Mol Cell Biol 31: 3531-3545, 2011.
203. Murata Y, Shimamura T, and Hamuro J. The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 14: 201-212, 2002.
204. Murray PJ and Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737, 2011.
205. Nagy L, Szanto A, Szatmari I, and Szeles L. Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol Rev 92: 739-789, 2012.
206. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, and Choi AM. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230, 2011.
207. Negre-Salvayre A, Hirtz C, Carrera G, Cazenave R, Troly M, Salvayre R, Penicaud L, and Casteilla L. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11: 809-815, 1997.
208. Nguyen NB, Callaghan KD, Ghio AJ, Haile DJ, and Yang F. Hepcidin expression and iron transport in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 291: L417-L425, 2006.
209. Nicholas SA and Sumbayev VV. The involvement of hypoxia-inducible factor 1 alpha in toll-like receptor 7/8-mediated inflammatory response. Cell Res 19: 973-983, 2009.
210. Nicholson AC. Expression of CD36 in macrophages and atherosclerosis: the role of lipid regulation of PPARgamma signaling. Trends Cardiovasc Med 14: 8-12, 2004.
211. Niecknig H, Tug S, Reyes BD, Kirsch M, Fandrey J, and Berchner-Pfannschmidt U. Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia. Free Radic Res 46: 705-717, 2012.
212. Niethammer P, Grabher C, Look AT, and Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459: 996-999, 2009.
213. Niu G, Briggs J, Deng J, Ma Y, Lee H, Kortylewski M, Kujawski M, Kay H, Cress WD, Jove R, and Yu H. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells. Mol Cancer Res 6: 1099-1105, 2008.
214. Nytko KJ, Maeda N, Schlafli P, Spielmann P, Wenger RH, and Stiehl DP. Vitamin C is dispensable for oxygen sensing in vivo. Blood 117: 5485-5493, 2011.
215. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Eagle AR, Vats D, Brombacher F, Ferrante AW, and Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447: 1116-1120, 2007.
216. Olagnier D, Lavergne RA, Meunier E, Lefevre L, Dardenne C, Aubouy A, Benoit-Vical F, Ryffel B, Coste A, Berry A, and Pipy B. Nrf2, a PPARgamma alternative pathway to promote CD36 expression on inflammatory macrophages: implication for malaria. PLoS Pathog 7: e1002254, 2011.
217. Olson N and van der Vliet A. Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. Nitric Oxide 25: 125-137, 2011.
218. Owings RA, Boerma M, Wang J, Berbee M, Laderoute KR, Soderberg LS, Vural E, and Jensen MH. Selective deficiency of HIF-1alpha in myeloid cells influences secondary intention wound healing in mouse skin. In Vivo 23: 879-884, 2009.
219. Park YM, Febbraio M, and Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 119: 136-145, 2009.
220. Pedruzzi E, Guichard C, Ollivier V, Driss F, Fay M, Prunet C, Marie JC, Pouzet C, Samadi M, Elbim C, O'Dowd Y, Bens M, Vandewalle A, Gougerot-Pocidalo MA, Lizard G, and Ogier-Denis E. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 24: 10703-10717, 2004.
221. Perkins ND. Integrating cell-signalling pathways with NFkappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62, 2007.
222. Persichini T, Mazzone V, Polticelli F, Moreno S, Venturini G, Clementi E, and Colasanti M. Mitochondrial type I nitric oxide synthase physically interacts with cytochrome c oxidase. Neurosci Lett 384: 254-259, 2005.
223. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, and Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14: 1583-1589, 2007.
224. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, and Nizet V. Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 178: 7516-7519, 2007.
225. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, and Johnson RS. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115: 1806-1815, 2005.
226. Pfeiffer S, Lass A, Schmidt K, and Mayer B. Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite. Faseb J 15: 2355-2364, 2001.
227. Poitz DM, Augstein A, Weinert S, Braun-Dullaeus RC, Strasser RH, and Schmeisser A. OxLDL and macrophage survival: essential and oxygen-independent involvement of the Hif-pathway. Basic Res Cardiol 106: 761-772, 2011.
228. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol 9: 259-270, 2009.
229. Poon IK, Hulett MD, and Parish CR. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ 17: 381-397, 2010.
230. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, and Pollard JW. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225, 2010.
231. Quintero M, Brennan PA, Thomas GJ, and Moncada S. Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation. Cancer Res 66: 770-774, 2006.
232. Rahman I, Marwick J, and Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 68: 1255-1267, 2004.
233. Ravishankar B, Liu H, Shinde R, Chandler P, Baban B, Tanaka M, Munn DH, Mellor AL, Karlsson MC, and McGaha TL. Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase. Proc Natl Acad Sci U S A 109: 3909-3914, 2012.
234. Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, Ting JP, Virgin HW, Kastan MB, and Semenkovich CF. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 15: 534-544, 2012.
235. Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, De Pizzol M, Zammataro L, Girelli D, and Cairo G. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol 40: 824-835, 2010.
236. Redente EF, Dwyer-Nield LD, Merrick DT, Raina K, Agarwal R, Pao W, Rice PL, Shroyer KR, and Malkinson AM. Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. Am J Pathol 176: 2972-2985, 2010.
237. Ricote M and Glass CK. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 1771: 926-935, 2007.
238. Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J, Witztum JL, Auwerx J, Palinski W, and Glass CK. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A 95: 7614-7619, 1998.
239. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, and Karin M. NFkappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811, 2008.
240. Robinson MA, Baumgardner JE, and Otto CM. Oxygendependent regulation of nitric oxide production by inducible nitric oxide synthase. Free Radic Biol Med 51: 1952-1965, 2011.
241. Roda JM, Wang Y, Sumner LA, Phillips GS, Marsh CB, and Eubank TD. Stabilization of HIF-2alpha induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model. J Immunol 189: 3168-3177, 2012.
242. Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, Cascante M, and Bosca L. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 185: 605-614, 2010.
243. Rosen GM, Pou S, Ramos CL, Cohen MS, and Britigan BE. Free radicals and phagocytic cells. FASEB J 9: 200-209, 1995.
244. Rubartelli A, Gattorno M, Netea MG, and Dinarello CA. Interplay between redox status and inflammasome activation. Trends Immunol 32: 559-566, 2011.
245. Sag D, Carling D, Stout RD, and Suttles J. Adenosine 5-monophosphate- activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 181: 8633-8641, 2008.
246. Sakamoto T and Seiki M. Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1. J Biol Chem 284: 30350-30359, 2009.
247. Sanmun D, Witasp E, Jitkaew S, Tyurina YY, Kagan VE, Ahlin A, Palmblad J, and Fadeel B. Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease. Am J Physiol Cell Physiol 297: C621-C631, 2009.
248. Schildknecht S, Karreman C, Daiber A, Zhao C, Hamacher J, Perlman D, Jung B, van der Loo B, O'Connor P, Leist M, Ullrich V, and Bachschmid MM. Autocatalytic nitration of prostaglandin endoperoxide synthase-2 by nitrite inhibits prostanoid formation in rat alveolar macrophages. Antioxid Redox Signal 17: 1393-1406, 2012.
249. Schodel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, and Mole DR. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117: e207-e217, 2011.
250. Schroder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, and Brandes RP. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110: 1217-1225, 2012.
251. Schuhmacher S, Foretz M, Knorr M, Jansen T, Hortmann M, Wenzel P, Oelze M, Kleschyov AL, Daiber A, Keaney JF, Jr., Wegener G, Lackner K, Munzel T, Viollet B, and Schulz E. alpha1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation. Arterioscler Thromb Vasc Biol 31: 560-566, 2011.
252. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, and Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336: 86-90, 2012.
253. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, Marck BT, Matsumoto AM, Shelton JM, Richardson JA, Bennett MJ, and Garcia JA. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/-mice. Nat Genet 35: 331-340, 2003.
254. Scull CM and Tabas I. Mechanisms of ER stress-induced apoptosis in atherosclerosis. Arterioscler Thromb Vasc Biol 31: 2792-2797, 2011.
255. Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL, Tsimikas S, Golenbock D, Moore KJ, and Tabas I. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12: 467-482, 2010.
256. Serhan CN and Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191-1197, 2005.
257. Serinkan BF, Gambelli F, Potapovich AI, Babu H, Di Giuseppe M, Ortiz LA, Fabisiak JP, and Kagan VE. Apoptotic cells quench reactive oxygen and nitrogen species and modulate TNF-alpha/TGF-beta1 balance in activated macrophages: involvement of phosphatidylserine-dependent and-independent pathways. Cell Death Differ 12: 1141-1144, 2005.
258. Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, and Gonzalez FJ. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134: 2036-2048, 2048. e1-e3, 2008.
259. Shatrov VA and Brune B. Induced expression of manganese superoxide dismutase by non-toxic concentrations of oxidized low-density lipoprotein (oxLDL) protects against oxLDL-mediated cytotoxicity. Biochem J 374: 505-511, 2003.
260. Shatrov VA, Sumbayev VV, Zhou J, and Brune B. Oxidized low-density lipoprotein (oxLDL) triggers hypoxiainducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms. Blood 101: 4847-4849, 2003.
261. Shen F, Hu Z, Goswami J, and Gaffen SL. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 281: 24138-24148, 2006.
262. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, Sher A, and Kehrl JH. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 13: 255-263, 2012.
263. Shirato K, Kizaki T, Sakurai T, Ogasawara JE, Ishibashi Y, Iijima T, Okada C, Noguchi I, Imaizumi K, Taniguchi N, and Ohno H. Hypoxia-inducible factor-1alpha suppresses the expression of macrophage scavenger receptor Pflugers Arch 459: 93-103, 2009.
264. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 91: 31S-38S, 1991.
265. Stamler JS, Lamas S, and Fang FC. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 106: 675-683, 2001.
266. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, and Remick DG. The pathogenesis of sepsis. Annu Rev Pathol 6: 19-48, 2011.
267. Stefater JA, 3rd, Ren S, Lang RA, and Duffield JS. Metchnikoff's policemen: macrophages in development, homeostasis and regeneration. Trends Mol Med 17: 743-752, 2011.
268. Stein M, Keshav S, Harris N, and Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292, 1992.
269. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 50 Suppl: S376-S381, 2009.
270. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, and Moore KJ. CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-161, 2010.
271. Strowig T, Henao-Mejia J, Elinav E, and Flavell R. Inflammasomes in health and disease. Nature 481: 278-286, 2012.
272. Stuehr DJ and Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 82: 7738-7742, 1985.
273. Stuehr DJ and Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543-1555, 1989.
274. Stuehr DJ, Santolini J, Wang ZQ, Wei CC, and Adak S. Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem 279: 36167-36170, 2004.
275. Sun Z, Chin YE, and Zhang DD. Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol Cell Biol 29: 2658-2672, 2009.
276. Sussan TE, Jun J, Thimmulappa R, Bedja D, Antero M, Gabrielson KL, Polotsky VY, and Biswal S. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS One 3: e3791, 2008.
277. Sussan TE, Rangasamy T, Blake DJ, Malhotra D, El-Haddad H, Bedja D, Yates MS, Kombairaju P, Yamamoto M, Liby KT, Sporn MB, Gabrielson KL, Champion HC, Tuder RM, Kensler TW, and Biswal S. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci U S A 106: 250-255, 2009.
278. Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, Kondo S, and Nishimura M. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 39: 673-682, 2008.
279. Tajima M, Kurashima Y, Sugiyama K, Ogura T, and Sakagami H. The redox state of glutathione regulates the hypoxic induction of HIF-1. Eur J Pharmacol 606: 45-49, 2009.
280. Takabe W, Li R, Ai L, Yu F, Berliner JA, and Hsiai TK. Oxidized low-density lipoprotein-activated c-Jun NH2-terminal kinase regulates manganese superoxide dismutase ubiquitination: implication for mitochondrial redox status and apoptosis. Arterioscler Thromb Vasc Biol 30: 436-441, 2010.
281. Takahashi K, Yamamura F, and Naito M. Differentiation, maturation, and proliferation of macrophages in the mouse yolk sac: a light-microscopic, enzyme-cytochemical, immunohistochemical, and ultrastructural study. J Leukoc Biol 45: 87-96, 1989.
282. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, and Fong GH. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein Mol Cell Biol 26: 8336-8346, 2006.
283. Takeda N, O'Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, Asagiri M, Simon MC, Hoffmann A, and Johnson RS. Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev 24: 491-501, 2010.
284. Takeda Y, Costa S, Delamarre E, Roncal C, Leite de Oliveira R, Squadrito ML, Finisguerra V, Deschoemaeker S, Bruyere F, Wenes M, Hamm A, Serneels J, Magat J, Bhattacharyya T, Anisimov A, Jordan BF, Alitalo K, Maxwell P, Gallez B, Zhuang ZW, Saito Y, Simons M, De Palma M, and Mazzone M. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479: 122-126, 2011.
285. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, and Harris AL. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157: 411-421, 2000.
286. Tassi S, Carta S, Vene R, Delfino L, Ciriolo MR, and Rubartelli A. Pathogen-induced interleukin-1beta processing and secretion is regulated by a biphasic redox response. J Immunol 183: 1456-1462, 2009.
287. Tateya S, Rizzo NO, Handa P, Cheng AM, Morgan-Stevenson V, Daum G, Clowes AW, Morton GJ, Schwartz MW, and Kim F. Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding. Diabetes 60: 2792-2801, 2011.
288. Tauber AI. Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol 4: 897-901, 2003.
289. Theurl I, Theurl M, Seifert M, Mair S, Nairz M, Rumpold H, Zoller H, Bellmann-Weiler R, Niederegger H, Talasz H, and Weiss G. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111: 2392-2399, 2008.
290. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C, Paolocci N, Ambs S, Colton CA, Harris CC, Roberts DD, and Wink DA. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 45: 18-31, 2008.
291. Tickner J, Fan LM, Du J, Meijles D, and Li JM. Nox2-derived ROS in PPARgamma signaling and cell-cycle progression of lung alveolar epithelial cells. Free Radic Biol Med 51: 763-772, 2011.
292. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME, and Tabas I. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest 119: 2925-2941, 2009.
293. Tontonoz P and Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77: 289-312, 2008.
294. Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene 24: 7567-7578, 2005.
295. Turpaev K, Bouton C, Diet A, Glatigny A, and Drapier JC. Analysis of differentially expressed genes in nitric oxideexposed human monocytic cells. Free Radic Biol Med 38: 1392-1400, 2005.
296. Turpaev K, Glatigny A, Bignon J, Delacroix H, and Drapier JC. Variation in gene expression profiles of human monocytic U937 cells exposed to various fluxes of nitric oxide. Free Radic Biol Med 48: 298-305, 2010.
297. Tyurina YY, Basova LV, Konduru NV, Tyurin VA, Potapovich AI, Cai P, Bayir H, Stoyanovsky D, Pitt BR, Shvedova AA, Fadeel B, and Kagan VE. Nitrosative stress inhibits the aminophospholipid translocase resulting in phosphatidylserine externalization and macrophage engulfment: implications for the resolution of inflammation. J Biol Chem 282: 8498-8509, 2007.
298. Tyurina YY, Serinkan FB, Tyurin VA, Kini V, Yalowich JC, Schroit AJ, Fadeel B, and Kagan VE. Lipid antioxidant, etoposide, inhibits phosphatidylserine externalization and macrophage clearance of apoptotic cells by preventing phosphatidylserine oxidation. J Biol Chem 279: 6056-6064, 2004.
299. Uderhardt S, Herrmann M, Oskolkova OV, Aschermann S, Bicker W, Ipseiz N, Sarter K, Frey B, Rothe T, Voll R, Nimmerjahn F, Bochkov VN, Schett G, and Kronke G. 12/ 15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 36: 834-846, 2012.
300. Uehara H and Shacter E. Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for Mer tyrosine kinase-mediated phagocytosis of apoptotic cells. J Immunol 180: 2522-2530, 2008.
301. Ullrich V and Schildknecht S. Sensing hypoxia by mitochondria: a unifying hypothesis involving S-nitrosation. Antioxid Redox Signal 2012 [Epub ahead of print]; DOI: ARS-2012-4788.
302. Van Assche T, Deschacht M, da Luz RA, Maes L, and Cos P. Leishmania-macrophage interactions: insights into the redox biology. Free Radic Biol Med 51: 337-351, 2011.
303. van Furth R, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG, and Langevoort HL. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ 46: 845-852, 1972.
304. van Uden P, Kenneth NS, and Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 412: 477-484, 2008.
305. Varol C, Zigmond E, and Jung S. Securing the immune tightrope:
306. Vaz M, Machireddy N, Irving A, Potteti HR, Chevalier K, Kalvakolanu D, and Reddy SP. Oxidant-induced cell death and Nrf2-dependent antioxidative response are controlled by Fra-1/AP-1. Mol Cell Biol 32: 1694-1709, 2012.
307. Vijayan V, Baumgart-Vogt E, Naidu S, Qian G, and Immenschuh S. Bruton's tyrosine kinase is required for TLRdependent heme oxygenase-1 gene activation via Nrf2 in macrophages. J Immunol 187: 817-827, 2011.
308. Villeneuve NF, Lau A, and Zhang DD. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal 13: 1699-1712, 2010.
309. Volkman A. Disparity in origin of mononuclear phagocyte populations. J Reticuloendothel Soc 19: 249-268, 1976.
310. Von Knethen A and Brune B. Activation of peroxisome proliferator- activated receptor gamma by nitric oxide in monocytes/macrophages down-regulates p47phox and attenuates the respiratory burst. J Immunol 169: 2619-2626, 2002.
311. von Knethen A, Soller M, Tzieply N, Weigert A, Johann AM, Jennewein C, Kohl R, and Brune B. PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages. J Cell Biol 176: 681-694, 2007.
312. von Knethen A, Tzieply N, Jennewein C, and Brune B. Casein-kinase-II- dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol. J Cell Sci 123: 192-201, 2010.
313. Vural E, Berbee M, Acott A, Blagg R, Fan CY, and Hauer-Jensen M. Skin graft take rates, granulation, and epithelialization: dependence on myeloid cell hypoxia-inducible factor 1alpha. Arch Otolaryngol Head Neck Surg 136: 720-723, 2010.
314. Wang D, Malo D, and Hekimi S. Elevated mitochondrial reactive oxygen species generation affects the immune response via hypoxia-inducible factor-1alpha in longlived Mclk1 + /-mouse mutants. J Immunol 184: 582-590, 2010.
315. Wang S, Zhang M, Liang B, Xu J, Xie Z, Liu C, Viollet B, Yan D, and Zou MH. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res 106: 1117-1128, 2010.
316. Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, Barrow AD, Diamond MS, and Colonna M. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 13: 753-760, 2012.
317. Weidemann A and Johnson RS. Biology of HIF-1alpha. Cell Death Differ 15: 621-627, 2008.
318. Weigert A and Brune B. Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric Oxide 19: 95-102, 2008.
319. Weigert A, Weichand B, and Brune B. S1P regulation of macrophage functions in the context of cancer. Anticancer Agents Med Chem 11: 818-829, 2011.
320. Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med 4: 557-591, 1998.
321. Weintz G, Olsen JV, Fruhauf K, Niedzielska M, Amit I, Jantsch J, Mages J, Frech C, Dolken L, Mann M, and Lang R. The phosphoproteome of toll-like receptor-activated macrophages. Mol Syst Biol 6: 371, 2010.
322. Weis N, Weigert A, von Knethen A, and Brune B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell 20: 1280-1288, 2009.
323. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, and Ting JP. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12: 408-415, 2011.
324. Wen H, Ting JP, and O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation?. Nat Immunol 13: 352-357, 2012.
325. Werno C, Menrad H, Weigert A, Dehne N, Goerdt S, Schledzewski K, Kzhyshkowska J, and Brune B. Knockout of HIF-1alpha in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis 31: 1863-1872, 2010.
326. Werth N, Beerlage C, Rosenberger C, Yazdi AS, Edelmann M, Amr A, Bernhardt W, von Eiff C, Becker K, Schafer A, Peschel A, and Kempf VA. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS ONE 5: e11576, 2010.
327. Whitley WD, Hancock WW, Kupiec-Weglinski JW, DeSousa M, and Tilney NL. Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats. Transplantation 56: 1182-1188, 1993.
328. Wijffels JF, de Rover Z, Beelen RH, Kraal G, and van Rooijen N. Macrophage subpopulations in the mouse spleen renewed by local proliferation. Immunobiology 191: 52-64, 1994.
329. Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, and Colton CA. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol 89: 873-891, 2011.
330. Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, Colton C, Vitek M, Feelisch M, and Grisham MB. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 3: 203-213, 2001.
331. Xie Z, Dong Y, Zhang M, Cui MZ, Cohen RA, Riek U, Neumann D, Schlattner U, and Zou MH. Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. J Biol Chem 281: 6366-6375, 2006.
332. Xie Z, Zhang J, Wu J, Viollet B, and Zou MH. Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes 57: 3222-3230, 2008.
333. Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, and Yamamoto M. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28: 2758-2770, 2008.
334. Yang Z, Kahn BB, Shi H, and Xue BZ. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem 285: 19051-19059, 2010.
335. Yeligar SM, Machida K, and Kalra VK. Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1alpha and Nrf2 to attenuate inflammatory cytokine expression. J Biol Chem 285: 35359-35373, 2010.
336. Zampell JC, Yan A, Avraham T, Daluvoy S, Weitman ES, and Mehrara BJ. HIF-1alpha coordinates lymphangiogenesis during wound healing and in response to inflammation. FASEB J 26: 1027-1039, 2012.
337. Zanoni I and Granucci F. Differences in lipopolysaccharideinduced signaling between conventional dendritic cells and macrophages. Immunobiology 215: 709-712, 2010.
338. Zhang H, Limphong P, Pieper J, Liu Q, Rodesch CK, Christians E, and Benjamin IJ. Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J 26: 1442-1451, 2012.
339. Zhou R, Tardivel A, Thorens B, Choi I, and Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140, 2010.
340. Zhou R, Yazdi AS, Menu P, and Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225, 2011.
341. Ziegler-Heitbrock HW. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45: 13-26, 1995.
342. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, and Lutz MB. Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-e80, 2010.
343. Zimmer M, Ebert BL, Neil C, Brenner K, Papaioannou I, Melas A, Tolliday N, Lamb J, Pantopoulos K, Golub T, and Iliopoulos O. Small-molecule inhibitors of HIF-2a translation link its 5UTR iron-responsive element to oxygen sensing. Mol Cell 32: 838-848, 2008.
344. Zitvogel L, Kepp O, and Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 140: 798-804, 2010.
345. Zmijewski JW, Banerjee S, Bae H, Friggeri A, Lazarowski ER, and Abraham E. Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem 285: 33154-33164, 2010.